CORRESP 2 filename2.htm Acceleration Request




[accelreq2021417_corresp001.jpg]


February 14, 2017


VIA EDGAR


Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549


Re:

Sigma Labs, Inc.

Registration Statement on Form S-1

File No. 333-212735


Ladies and Gentlemen:


Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of Sigma Labs, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:15 p.m. (Washington, D.C. time) on Tuesday, February 14, 2017, or as soon as practicable thereafter.


In connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated February 8, 2017 were distributed to the following persons in the following approximate amounts:


To Whom Distributed

 

Number of Copies

 

 

 

Institutions

 

14

Individuals

 

1,067

Total

 

1,081  


We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

Sincerely,


Dawson James Securities, Inc.


By:  /s/ Robert D. Keyser, Jr.            

Name: Robert D. Keyser, Jr.

Title:   Chief Executive Officer